These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6133617)

  • 1. Animal models of tardive dyskinesias.
    Klawans HL; Goetz CG; Carvey P
    Clin Neuropharmacol; 1983 Jun; 6(2):129-35. PubMed ID: 6133617
    [No Abstract]   [Full Text] [Related]  

  • 2. The pathophysiology of tardive dyskinesia.
    Klawans HL; Carvey P; Tanner CM; Goetz CG
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. U-74500A (lazaroid), a 21-aminosteroid attenuates neuroleptic-induced orofacial dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):601-5. PubMed ID: 18193111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tardive dyskinesia: are first signs reversible?
    Quitkin F; Rifkin A; Gochfeld L; Klein DF
    Am J Psychiatry; 1977 Jan; 134(1):84-7. PubMed ID: 12666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molindone compared to haloperidol in a guinea-pig model of tardive dyskinesia.
    Koller W; Curtin J; Fields J
    Neuropharmacology; 1984 Oct; 23(10):1191-4. PubMed ID: 6240609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and pathophysiology of tardive dyskinesias.
    Klawans HL; Tanner CM; Goetz CG
    Adv Neurol; 1988; 49():185-97. PubMed ID: 2894124
    [No Abstract]   [Full Text] [Related]  

  • 8. MK-771 antagonizes the enhanced response to apomorphine in rats treated chronically with haloperidol - implications for tardive dyskinesia.
    Yarbrough GG; Faison EP; Antolik EK
    Neurosci Lett; 1982 Dec; 34(3):321-3. PubMed ID: 6819493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for models of tardive dyskinesia.
    Glassman RB; Glassman HN
    Psychopharmacology (Berl); 1980; 69(1):19-25. PubMed ID: 6104844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choline chloride in animal models of tardive dyskinesia.
    Davis KL; Hollister LE; Vento AL; Simonton S
    Life Sci; 1978 May; 22(19):1699-707. PubMed ID: 566830
    [No Abstract]   [Full Text] [Related]  

  • 11. Spontaneous and tardive dyskinesias: clinical and laboratory studies.
    Casey DE
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):42-7. PubMed ID: 2858480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tardive dyskinesia presenting as gastrointestinal disorder.
    Goldberg RJ; Morris PL; Lidofsky S
    J Clin Psychiatry; 1990 Jun; 51(6):253-4. PubMed ID: 1971823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration.
    Gao XM; Hashimoto T; Cooper TB; Tamminga CA
    J Neural Transm (Vienna); 1997; 104(1):97-104. PubMed ID: 9085197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of lithium on an animal model of tardive dyskinesia.
    Klawans HL; Weiner WJ; Nausieda PA
    Prog Neuropsychopharmacol; 1977; 1(1-2):53-60. PubMed ID: 569341
    [No Abstract]   [Full Text] [Related]  

  • 15. Instrumental assessment of lingual motor instability in tardive dyskinesia.
    Caligiuri MP; Jeste DV; Harris MJ
    Neuropsychopharmacology; 1989 Dec; 2(4):309-12. PubMed ID: 2575388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental tardive dyskinesia.
    Gunne LM; Häggström JE
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):48-50. PubMed ID: 2858481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential enhancement of locomotor activity by dopamine agonists following chronic neuroleptic treatment: an animal model of tardive dyskinesia.
    Tye NC; Horsman L; Wright FC; Pullar IA
    Eur J Pharmacol; 1979 Apr; 55(1):103-7. PubMed ID: 35357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar effect of estradiol and haloperidol on experimental tardive dyskinesia in monkeys.
    Bédard PJ; Boucher R; Daigle M; Di Paolo T
    Psychoneuroendocrinology; 1984; 9(4):375-9. PubMed ID: 6514933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):451-61. PubMed ID: 17988775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine in tardive dyskinesia: observations from human and animal model studies.
    Tamminga CA; Thaker GK; Moran M; Kakigi T; Gao XM
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.